2017 -- H 5218

========

LC000735

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2017

____________

A N   A C T

RELATING TO INSURANCE - INSURANCE COVERAGE FOR MENTAL ILLNESS AND

SUBSTANCE ABUSE

     

     Introduced By: Representatives Serpa, Fellela, Jacquard, Ackerman, and Vella-
Wilkinson

     Date Introduced: January 26, 2017

     Referred To: House Corporations

     (Attorney General)

It is enacted by the General Assembly as follows:

1

     SECTION 1. Section 27-38.2-1 of the General Laws in Chapter 27-38.2 entitled

2

"Insurance Coverage for Mental Illness and Substance Abuse" is hereby amended to read as

3

follows:

4

     27-38.2-1. Coverage for the treatment of mental health and substance use disorders.

5

     (a) A group health plan and an individual or group health insurance plan shall provide

6

coverage for the treatment of mental health and substance-use disorders under the same terms and

7

conditions as that coverage is provided for other illnesses and diseases.

8

     (b) Coverage for the treatment of mental health and substance-use disorders shall not

9

impose any annual or lifetime dollar limitation.

10

     (c) Financial requirements and quantitative treatment limitations on coverage for the

11

treatment of mental health and substance-use disorders shall be no more restrictive than the

12

predominant financial requirements applied to substantially all coverage for medical conditions in

13

each treatment classification.

14

     (d) Coverage shall not impose non-quantitative treatment limitations for the treatment of

15

mental health and substance-use disorders unless the processes, strategies, evidentiary standards,

16

or other factors used in applying the non-quantitative treatment limitation, as written and in

17

operation, are comparable to, and are applied no more stringently than, the processes, strategies,

18

evidentiary standards, or other factors used in applying the limitation with respect to

 

1

medical/surgical benefits in the classification.

2

     (e) The following classifications shall be used to apply the coverage requirements of this

3

chapter: (1) Inpatient, in-network; (2) Inpatient, out-of-network; (3) Outpatient, in-network; (4)

4

Outpatient, out-of-network; (5) Emergency care; and (6) Prescription drugs.

5

     (f) Medication-assisted treatment or medication-assisted maintenance services of

6

substance-use disorders, opioid overdoses, and chronic addiction, including methadone,

7

buprenorphine, naltrexone, or other clinically appropriate medications, is included within the

8

appropriate classification based on the site of the service.

9

     (g) Payors shall rely upon the criteria of the American Society of Addiction Medicine

10

when developing coverage for levels of care for substance-use disorder treatment.

11

     (h) A payor may not deny continued residential or inpatient treatment coverage due to

12

medical necessity and appropriateness of treatment under ยง27-38.2-3 if the subscriber has been

13

admitted and is currently in residential or inpatient services for a mental health and/or substance

14

use disorder and the provider of treatment has recommended continued residential or inpatient

15

treatment for mental health based upon a clinical assessment or for substance use disorder based

16

upon the criteria of the American Society of Addiction Medicine.

17

     SECTION 2. This act shall take effect upon passage.

========

LC000735

========

 

LC000735 - Page 2 of 3

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO INSURANCE - INSURANCE COVERAGE FOR MENTAL ILLNESS AND

SUBSTANCE ABUSE

***

1

     This act would provide that a payor may not deny continued residential or inpatient

2

treatment coverage due to medical necessity and appropriateness of treatment under Rhode Island

3

law if the subscriber has been admitted and is currently in residential or inpatient services for a

4

mental health and/or substance use disorder and the provider of treatment has recommended

5

continued residential or inpatient treatment.

6

     This act would take effect upon passage.

========

LC000735

========

 

LC000735 - Page 3 of 3